Evaluasi Penggunaan Obat dan Kesesuaian Dosis Kemoterapi Body Surface Area (BSA) Pasien Kanker Payudara di RSUD Sekayu

Authors

  • Kiki Amelia Sekolah Tinggi Ilmu Farmasi Bhakti Pertiwi, Palembang, Sumatera Selatan
  • Doddy Rusli Sekolah Tinggi Ilmu Farmasi Bhakti Pertiwi, Palembang, Sumatera Selatan
  • Melinda Hikmah Sekolah Tinggi Ilmu Farmasi Bhakti Pertiwi, Palembang, Sumatera Selatan

DOI:

https://doi.org/10.21111/pharmasipha.v6i2.8708

Keywords:

breast cancer, chemotherapy drugs, body surface area (BSA)

Abstract

Research has been conducted on the description of the use of chemotherapy drugs and evaluation of the suitability of doses with the method of body surfeace area (BSA) in breast cancer patients (ca.mamae) at the Sekayu Regional General Hospital. The purpose of this study is to find out an overview of the use of drugs and doses given in chemotherapy patients. This research is descriptive with retrospective data retrieval method where data is obtained from the medical records of patients diagnosed with breast cancer in the period January-December 2019. Data retrieval technique in the form of total sampling, obtained 18 samples according to inclusion criteria.The results of the study obtained is on the use of chemotherapy drugs all patients get fac drug regimen as many as 18 patients (100%) and evaluation of dose conformity calculation obtained by 17 patients (94.44%) obtained an inappropriate dose and 1 patient (5,56%) get the appropriate dosage. From the results of the study obtained that the chemotherapy drug used is a first-line chemotherapy drug is in accordance with the treatment guidelines and the dose used has not been in accordance with the calculation based on the body surface area (BSA).

Downloads

Published

2022-10-01

Issue

Vol. 6 No. 2 (2022): September

Section

Articles

License

Authors who publish with this Journal agree to the following terms:

  1. Author retain copyright and grant the journal right of first publication with the work simultaneously licensed under a creative commons attribution license that allow others to share the work within an acknowledgement of the work’s authorship and initial publication of this journal.
  2. Authors are able to enter into separate, additional contractual arrangement for the non-exclusive distribution of the journal’s published version of the work (e.g. acknowledgement of its initial publication in this journal).
  3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published works.